Key result
Among 138 patients undergoing cardiac surgery, 62% received prophylactic rate control medications prior to surgery, and 36% developed postoperative atrial fibrillation.
Why the study?
Postoperative atrial fibrillation causes morbidity and extended hospital stay after cardiac surgery, prompting an evaluation of adherence to NICE guidance recommending prophylaxis.
Does adherence to NICE guidance for prophylactic rate control prior to cardiac surgery reduce the incidence of postoperative atrial fibrillation and improve patient outcomes?
Observational (n=138)
No
Does adherence to NICE guidance for prophylactic rate control prior to cardiac surgery reduce the incidence of postoperative atrial fibrillation and improve patient outcomes?
A significant proportion of patients undergoing cardiac surgery do not receive guideline-recommended prophylactic rate control, and the subsequent development of postoperative atrial fibrillation is associated with prolonged hospital stays.
Poor adherence to POAF prophylaxis guidelines observed; leaves open whether quality initiatives improve uptake and outcomes.
BACKGROUND: Acute onset atrial fibrillation is a common dysrhythmia experienced by patients following cardiac surgery which can often cause morbidity and extended hospital length of stay. The primary aim of the study was to explore adherence to National Institute for Health and Care Excellence (NICE) guidance which suggests the need for prophylaxis for postoperative atrial fibrillation (POAF). Secondary aims were to explore factors contributing to the development POAF and the impact of POAF on patient-centred outcomes. METHODS: An analysis consisting of descriptive statistics and regression models was conducted using 138 patient's records who underwent cardiac surgery between January and March 2017. RESULTS: We identified 83 (62%) patients on prophylactic rate control medications prior to surgery. During the study period, a total of 50 patients (36%) developed POAF, of which 28 were on prophylactic medication prior to surgery. Patients who developed POAF had significantly prolonged hospital length of stay compared to those who did not develop POAF. CONCLUSION: Our study identified a significant proportion of patients not being offered prophylactic rate control prior to cardiac surgery. It is clear that poor patient outcomes are associated with the development of POAF and therefore there is an important need to ensure preventative measures are implemented in guidance relating to the management of these patients. Our results also suggest that tight management of clinical and physiological risk factors prior and during cardiac surgery may improve outcomes in this group of patients and could be considered in future enhanced recovery after cardiac surgery protocols.
No takes yet. Share an insight, caveat, or question.
Zochios et al. (2019) conducted an observational in Postoperative atrial fibrillation (n=138). Prophylactic rate control medications vs. No prophylactic rate control medications was evaluated on Adherence to NICE guidance for POAF prophylaxis. Among 138 patients undergoing cardiac surgery, 62% received prophylactic rate control medications prior to surgery, and 36% developed postoperative atrial fibrillation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: